Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
The 340B Drug Pricing Program; H.R.4390 - PROTECT 340B Act of 2021; Labor HHS Appropriations FY 2023; HR853 Closing Loopholes for Orphan Drugs Act; S. 2837, the 340B Accountability Act of 2021
The 340B Drug Pricing Program; H.R.4390 - PROTECT 340B Act of 2021; Labor HHS Appropriations FY 2023; HR853 Closing Loopholes for Orphan Drugs Act; S. 2837, the 340B Accountability Act of 2021
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2022 · second_quarter · Q2
The 340B Drug Pricing Program; H.R.4390 - PROTECT 340B Act of 2021; Labor HHS Appropriations FY 2023; HR853 Closing Loopholes for Orphan Drugs Act; S. 2837, the 340B Accountability Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Source: Senate LDA
The 340B Drug Pricing Program; H.R.4390 - PROTECT 340B Act of 2021; Labor HHS Appropriations FY 2023; HR853 Closing Loopholes for Orphan Drugs Act; S. 2837, the 340B Accountability Act of 2021